EVI
AMEX · Trading Companies & Distributors
Evi Industries Inc
$21.40
+0.82 (+3.98%)
EVI News30 articles
Intel Q1 Earnings Preview: AI Demand and 18A Yields in Spotlight
Intel is scheduled to release its first-quarter 2026 financial results on April 23, after the market closes. The chipmaker's performance will be scrutinized for updates on server supply constraints, advanced manufacturing yields, and its competitive positioning in AI.
Snap Jumps on Activist Pressure for AI Focus, Cost Cuts, and Specs Review
Snap shares climbed sharply after activist investor Irenic Capital disclosed a stake and urged the company to sharpen its AI focus, cut costs, and reconsider its Specs division. The company recently returned to profitability but issued soft Q1 guidance.
GE Aerospace Faces Shareholder Pushback on Human Rights Review Proposal
Two shareholder groups are urging GE Aerospace investors to vote against a proposal calling for an independent review of human rights risk assessments in defense sales. The company's board opposes the measure ahead of the May 5 annual meeting.
Grab's $600M Taiwan Expansion Faces Antitrust Review Over Uber Ties
Grab Holdings' planned $600 million acquisition of Foodpanda Taiwan is under regulatory review, with authorities examining Uber's influence as a major shareholder. The deal, expected to close in late 2026, represents Grab's first move beyond its Southeast Asian home market.
Ondas Shares Slide on Accounting-Driven Profit Revision
Ondas Holdings shares declined 6.4% following a revised financial outlook that attributed a $102 million profit boost to an accounting adjustment rather than operational improvement. The company maintained its revenue guidance.
Ondas Stock Drops Despite Q4 Profit Revision Ahead of Earnings
Ondas Holdings shares declined 5% to $10.19 after the company updated its Q4 forecast from a loss to a profit, citing a $102 million non-cash accounting gain. Revenue guidance remains unchanged.
Denison Mines Shares Slide Amid Phoenix Uranium Project Cost Revisions
Denison Mines Corp. shares declined 6.3% to $3.58, underperforming the broader market, following an increased capital estimate for its flagship Phoenix uranium project. The company reported a significant 2025 net loss of $217.3 million against modest revenue.
Ford Shares Slide Amid Renewed EV Doubts, Honda Charge Revives Industry Concerns
Ford Motor shares declined 2% to $11.80, underperforming a broader market rebound, as Honda's significant EV restructuring charge reignited concerns about Ford's own substantial writedowns and the automotive sector's costly transition to electric vehicles.
Northern Star Revises FY26 Gold Forecast Amid Operational Challenges
Northern Star Resources Ltd has cautioned that its full-year 2026 gold production could fall short of previous guidance, citing operational difficulties at its KCGM and Jundee sites. The miner now anticipates output exceeding 1.5 million ounces, below its earlier 1.6-1.7 million ounce range.
FTSE 100 Slips as $100 Oil Revives Inflation Fears, Shifts Rate Expectations
London's FTSE 100 declined 0.47% to 10,305.15 as surging oil prices revived inflation concerns, causing traders to shift expectations toward potential Bank of England rate hikes. HSBC shares fell sharply following branch closures in Qatar.
Atara Biotherapeutics Surges on FDA Leadership Shift, EBVALLO Review in Focus
Atara Biotherapeutics shares surged 18% Monday following news of an upcoming FDA leadership change, reviving investor hope for a reconsideration of its rejected EBVALLO therapy for a rare blood cancer.
Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting
Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.
Hims & Hers Shares Jump on Novo Nordisk Partnership Revival
Hims & Hers Health shares surged in premarket trading Monday following reports that Novo Nordisk will resume selling its weight-loss drugs through the telehealth platform. The move marks a reversal from a patent dispute last month.
California Antitrust Review Clouds Paramount's $110B Warner Bros. Discovery Acquisition
California's attorney general has opened an antitrust investigation into Paramount's planned $110 billion acquisition of Warner Bros. Discovery, casting doubt on the merger's timeline and approval.
ANZ Revises Key Financial Calendar, Moves Half-Year Results Forward
ANZ Group has rescheduled its half-year financial results to May 1, six days earlier than previously planned, and adjusted the timetable for its interim dividend distribution.
LSEG Shares Slide Following Buyback Announcement, Market Eyes FTSE Review
London Stock Exchange Group shares declined nearly 2% in early trading after the company announced a £52 million share repurchase. Investors are also awaiting the results of the FTSE UK index quarterly review.
Verizon Rises on Sponsorship Review, Legal Clash with T-Mobile Intensifies
Verizon shares climbed 1.8% to $50.90 following news the company is evaluating its high-value sponsorships, including its NFL deal, while simultaneously facing a false advertising countersuit from rival T-Mobile.
Broadcom Earnings Preview: Analysts Bullish on AI Demand, Options Activity Surges
Broadcom is set to report fiscal first-quarter earnings after the close on March 4. Analysts at Baird and Oppenheimer maintain bullish price targets, anticipating strong results driven by artificial intelligence demand.
Broadcom Earnings Preview: Analysts Bullish on AI Demand as Options Activity Surges
Broadcom prepares to release fiscal first-quarter results on March 4, with analysts from Baird and Oppenheimer maintaining bullish stances citing strong AI-driven demand. Options activity remains elevated ahead of the report.
Broadcom Earnings Preview: Analysts Bullish on AI Demand as Options Activity Surges
Broadcom is set to report fiscal first-quarter earnings after the close on March 4. Analysts at Baird and Oppenheimer maintain bullish ratings, anticipating strong results driven by artificial intelligence demand.
Chevron's Leviathan Gas Field Shutdown Sparks Energy Market Jitters
Israel has temporarily shut down Chevron-operated natural gas fields, including the major Leviathan site, following military action against Iran. The move heightens supply concerns as shipping through the Strait of Hormuz also stalls.
Indian Markets Brace for Volatility Amid AI Fears, GDP Revision, and Shortened Week
Indian equities closed February with significant losses, led by a historic selloff in IT stocks due to AI earnings fears. A shortened trading week and revised GDP data add to market uncertainty.
HKEX Eyes IPO Revival and Policy Signals as Key Catalysts
HKEX shares gained 0.87% to HK$419.00, with a revived IPO pipeline and upcoming policy meetings in Beijing setting the near-term agenda. The exchange reported record 2025 profits of HK$17.8 billion.
Analog Devices Gains Amid Inflation Jitters, Eyes CFO Remarks and Dividend
Analog Devices shares advanced Friday, outperforming some peers despite tech pressure from hot inflation data. The company's CFO is scheduled to speak March 3, which is also the record date for its newly raised quarterly dividend.
Indian Markets Stagnate Ahead of Key GDP Revision; IT Sector Slumps
Indian equity benchmarks ended nearly unchanged on Thursday, with the Nifty 50 edging up 0.06% to 25,496.55. Investor focus shifts to Friday's revised GDP figures and a critical base-year update.
Tel Aviv Bourse Shares Surge 6% on Volume Revival Ahead of Key Central Bank Decision
Shares of the Tel Aviv Stock Exchange operator jumped 6.4% on Friday, recovering from a prior decline, as trading volumes increased following its schedule change. The market now awaits the Bank of Israel's policy announcement on Monday.
HKEX Earnings Preview: IPO Pipeline and Market Reforms in Focus
HKEX shares edged down 0.24% to HK$407.80 in volatile Friday trading as investors await February 26 earnings. Chairman Carlson Tong reported 488 companies in IPO pipeline with 24 listings raising HK$87 billion so far in 2026.
LSEG Shares Rise as Elliott Demands Strategic Review and Buyback
London Stock Exchange Group shares advanced 0.3% after Elliott Investment Management urged a strategic review and a £5 billion share repurchase program. The news comes as LSEG announced major data partnerships with Standard Chartered and Bank of America.
Fortescue Faces Dual Catalysts with Mine Review and Earnings
Fortescue Metals Group shares gained 0.5% as regulators began a public comment period for its proposed Wyloo North iron ore mine, with investors also positioning for the company's half-year financial results scheduled for February 25.
Fortescue Gains as Wyloo Mine Enters Public Review, Results Loom
Fortescue shares advanced slightly as regulators began a public feedback period for its proposed Wyloo North iron ore mine. Investors are focused on the upcoming comment deadline and the company's half-year financial report.